Recruiting
Phase 1

LY4152199

Sponsor:

Eli Lilly and Company

Code:

NCT07101328

Conditions

Lymphoma, Non-Hodgkin

B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Follicular

Lymphoma, B-cell Marginal Zone

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY4152199 - IV

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-14. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-07-10.